Home
>
National Drug Code (NDC)
>
Zanosar
Zanosar - 0703-4636-01 - (streptozocin)
Drug Information of Zanosar
| Product NDC: | 0703-4636 |
| Proprietary Name: | Zanosar |
| Non Proprietary Name: | streptozocin |
| Active Ingredient(s): | 100 mg/mL & nbsp; streptozocin |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Zanosar
| Product NDC: | 0703-4636 |
| Labeler Name: | Teva Parenteral Medicines, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050577 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20031203 |
Package Information of Zanosar
| Package NDC: | 0703-4636-01 |
| Package Description: | 10 mL in 1 VIAL (0703-4636-01) |
NDC Information of Zanosar
| NDC Code | 0703-4636-01 |
| Proprietary Name | Zanosar |
| Package Description | 10 mL in 1 VIAL (0703-4636-01) |
| Product NDC | 0703-4636 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | streptozocin |
| Dosage Form Name | POWDER, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20031203 |
| Marketing Category Name | NDA |
| Labeler Name | Teva Parenteral Medicines, Inc. |
| Substance Name | STREPTOZOCIN |
| Strength Number | 100 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |
